| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Transforming growth factor beta-1 proprotein|Latency-associated peptide|LAP|Transforming growth factor beta-1|TGF-beta-1|TGFB1|TGFB |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
mouse TGF-β1 (Transforming Growth Factor β1) is a molecular target commonly studied in immunology, cardiovascular, and cancer research. Growth factors are signaling proteins that influence proliferation, differentiation, and tissue remodeling through receptor activation.
Biological role and mechanism
The biological role of TGF-β1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of TGF-β1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
TGF-β1 (Transforming Growth Factor β1) may also be referenced as Transforming growth factor beta-1 proprotein, Latency-associated peptide, and LAP in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how TGF-β1 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, cardiovascular, and cancer research.
- Interpreting shifts in TGF-β1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
TGF-β1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, cardiovascular, and cancer studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Sono-Responsive Hydrogel for Fractionated PROTAC Release to Alleviate Resistance and Immunosuppression Induced by Multi-Course Postoperative Radiotherapy
IF: 19 Journal: Advanced Functional Materials Author: Department of Radiology, The Second Affiliated Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442 P. R. China Cited Date: 2025-10-17
Neuroprotective effects of intraperitoneally injected Mg alloy extracts on middle cerebral artery occluded mouse with reperfusion injury
IF: 17.6 Journal: Journal of Magnesium and Alloys Author: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China Cited Date: 2024-06-28
Hybrid Exosome–Liposome Nanoparticles for Dual Modulation of Neuroinflammation and Lipid Metabolism in Ischemic Stroke
IF: 16 Journal: ACS Nano Author: Department of Pharmacy, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi 530021, China. Cited Date: 2025-10-17
Velcro-Inspired Poly (ethylene glycol) Gel (PEGgel) for Robust Interface Adhesion Between Hydrogel, Device, and Tissue
IF: 16 Journal: ACS Nano Author: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, PR China. Cited Date: 2025-10-17
Immunity/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12/CXCR4 and adenosine-A2AR pathways
IF: 12.8 Journal: Biomaterials Author: Department of Radiology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, PR China. Cited Date: 2025-03-07
Potentiating immunotherapy in “immune-cold” solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering
IF: 10.6 Journal: Cell Reports Medicine Author: School of Life Science, Beijing Institute of Technology, Beijing 100081, China. Cited Date: 2025-12-26